Emerging proteomic technologies offer new insight in the study of malignant tumor to identify protein biomarkers for early detection, stratification, prediction and monitoring of treatment, as well as to detect target molecules for therapy. The tumor protein biomarker is responsible for the regulation of the cell cycle to promote cell proliferation …
Recurrent pregnancy loss, one of the crucial reproductive health concerns affecting 6% of couples. Clinically recognized pregnancy loss is familiar, occurring in approximately 15-25% cases of pregnancy. The most common cause of recurrent pregnancy loss is cytogenetic anomaly, antiphospholipid antibody, metabolic and hormonal disorders. However, appr…
The use of mass spectrometry (MS) to measure proteins has grown exponentially over the past 25 years. This growth has been primarily driven by the advent of proteomics in which scientists have developed methods to identify and quantitate as many proteins in a complex mixture as possible. Early studies trended towards the development of techniques t…